Comprehensive database of marijuana prices across legal U.S. states, including both recreational and medical cannabis markets.

The District of Columbia holds the record for the highest price per ounce of high quality marijuana in the United States, as of January 2025, with an average price of some 590 U.S. dollars per ounce. Recreational cannabis use Recreational cannabis is not legal in all U.S. states; however, many consumers use the drug illicitly. A recent survey indicated that over half of U.S. adults think that cannabis should be legalized and taxed like alcohol and tobacco. Recreational cannabis is often used by consumers for relaxation, stress relief, and creativity, to name a few. Surveys have shown that a majority of recreation users use marijuana for relaxation. Legal marijuana market potential It is projected that by 2025 the sales of legal cannabis in the U.S. will generate approximately 25 billion dollars in revenue. The regulation of marijuana includes the taxation of all sales. There is potential for the U.S. cannabis market to generate significant taxes and boost the economy. It is estimated that the taxes from legal marijuana sales would exceed the taxes earned from U.S. sales taxes by a significant amount.

This statistic presents the average price per ounce of marijuana in selected cities in Colorado between February and July 2024, in U.S. dollars. The price for medium quality marijuana in Colorado Springs stood at 100 U.S. dollars per ounce on February 4, 2024.

Aurora Cannabis reported CAD78.85M in Cost of Sales for its fiscal quarter ending in December of 2024. Data for Aurora Cannabis | ACB - Cost Of Sales including historical, tables and charts were last updated by Trading Economics this last July in 2025.

Canopy Growth reported CAD50.66M in Cost of Sales for its fiscal quarter ending in December of 2024. Data for Canopy Growth | WEED - Cost Of Sales including historical, tables and charts were last updated by Trading Economics this last July in 2025.

Canopy Growth reported CAD-23822000 in Operating Profit for its fiscal quarter ending in December of 2024. Data for Canopy Growth | WEED - Operating Profit including historical, tables and charts were last updated by Trading Economics this last July in 2025.

Canopy Growth reported CAD341.08M in Current Assets for its fiscal quarter ending in December of 2024. Data for Canopy Growth | WEED - Current Assets including historical, tables and charts were last updated by Trading Economics this last July in 2025.

Canopy Growth reported CAD467.93M in Loan Capital for its fiscal quarter ending in December of 2024. Data for Canopy Growth | WEED - Loan Capital including historical, tables and charts were last updated by Trading Economics this last July in 2025.

IM Cannabis market cap as of June 21, 2025 is $0B. IM Cannabis market cap history and chart from 2021 to 2025. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.

Canopy Growth reported CAD90.75M in Stock for its fiscal quarter ending in December of 2024. Data for Canopy Growth | WEED - Stock including historical, tables and charts were last updated by Trading Economics this last July in 2025.

Canopy Growth reported CAD143.05M in Market Capitalization this July of 2025, considering the latest stock price and the number of outstanding shares.Data for Canopy Growth | WEED - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last July in 2025.

The marijuana vaporizer market is experiencing robust growth, driven by increasing legalization of cannabis for both medical and recreational use globally. The market's expansion is fueled by several key factors, including the perception of vaping as a healthier alternative to smoking, the rising popularity of cannabis-infused products, and technological advancements leading to more efficient and user-friendly devices. The market is segmented by application (personal, medical, other) and type (chargeable, battery). The medical application segment is expected to witness significant growth due to the increasing acceptance of cannabis as a treatment for various medical conditions. Technological advancements in battery technology and the development of sophisticated vaporizer designs contribute to the market's expansion. The preference for discreet consumption further boosts demand, especially in regions where cannabis use is still regulated. Competition among established and emerging players is intense, leading to innovation in product design, features, and pricing. North America currently holds a dominant market share, largely attributed to the early adoption of cannabis legalization in certain states. However, growing acceptance in Europe and Asia-Pacific is projected to drive substantial regional growth in the coming years. Despite these positive trends, regulatory hurdles in some regions and potential health concerns associated with vaping remain as market restraints. This dynamic interplay of drivers and restraints shapes the market's trajectory towards a sustained period of expansion. The forecast period of 2025-2033 is expected to witness a substantial increase in market value. Assuming a conservative CAGR (let's assume 15%, a reasonable estimate given market trends), and starting with a 2025 market size (let's assume $2 Billion as a reasonable estimate based on similar emerging markets), the market is poised for significant expansion. Growth will be fueled by the increasing availability of cannabis products, continued technological advancements in vaporizer design, and expanding legalization efforts globally. Regional growth will be uneven, with North America maintaining a leading position while other regions like Europe and Asia-Pacific show accelerated growth due to changing regulatory landscapes and consumer preferences. The competition between established players and new entrants will likely lead to product differentiation and innovative marketing strategies. Pricing strategies, product features (like portability and ease of use), and brand recognition will play critical roles in market share gains.

Canopy Growth reported CAD98.58M in Operating Expenses for its fiscal quarter ending in December of 2024. Data for Canopy Growth | WEED - Operating Expenses including historical, tables and charts were last updated by Trading Economics this last July in 2025.

448 Global export shipment records of Cannabis with prices, volume & current Buyer's suppliers relationships based on actual Global export trade database.

Canopy Growth reported CAD1.16B in Assets for its fiscal quarter ending in December of 2024. Data for Canopy Growth | WEED - Assets including historical, tables and charts were last updated by Trading Economics this last July in 2025.

Canopy Growth reported CAD74.76M in Sales Revenues for its fiscal quarter ending in December of 2024. Data for Canopy Growth | WEED - Sales Revenues including historical, tables and charts were last updated by Trading Economics this last July in 2025.

Current marijuana use among U.S. adults in 2022 was highest in Vermont, where around 34.37 percent of adults reported using marijuana within the past year. In recent years, a number of U.S. states, including Colorado and California, have legalized the sale of marijuana for recreational use. In 2022, around 132 million people in the United States reported that they had used marijuana at least once in their lifetime.

Consumer behavior Starting around 2013, the majority of U.S. adults now say they are in favor of legalizing marijuana in the United States. The share of adults who were in favor of legalization has continued to increase over the years. As of 2021, about 68 percent of U.S. adults aged 18 and older were in favor of legalization. Legal sales of marijuana reached 16.5 billion U.S. dollars in 2021, and are expected to increase to around 37 billion dollars by the year 2026.

COVID-19 impact on marijuana use The COVID-19 pandemic and resulting lockdowns led to fears of an increase in substance abuse in many parts of the world. In March 2020, around 40 percent of millennials who used cannabis in the past year reported that they planned to increase their marijuana use during the COVID-19 pandemic. This rise in usage was reflected in sales early in the pandemic. In California for example, sales of marijuana on March 16, 2020 increased 159 percent compared to the same day in 2019.

Canopy Growth reported CAD489.67M in Debt for its fiscal quarter ending in December of 2024. Data for Canopy Growth | WEED - Debt including historical, tables and charts were last updated by Trading Economics this last July in 2025.

Aurora Cannabis reported CAD348.25M in Market Capitalization this July of 2025, considering the latest stock price and the number of outstanding shares.Data for Aurora Cannabis | ACB - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last July in 2025.

Canopy Growth stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.